Prostacyclin Analogues and Prostacyclin Receptors Agonists in Pulmonary Arterial Hypertension: Review
نویسندگان
چکیده
منابع مشابه
Advances in prostacyclin therapy for pulmonary arterial hypertension.
To purchase reprints, contact The InnoVision Group, 101 Columbia, Aliso Viejo, CA 92656. Phone, (800) 8092273 or (949) 362-2050 (ext 532); fax, (949) 362-2049; e-mail, [email protected]. ing from disorders that affect the pulmonary vasculature. Before the World Health Organization reclassification, the aforementioned categories were referred to as secondary pulmonary hypertension. Patients with...
متن کاملOral prostacyclin therapy for pulmonary arterial hypertension: another step forward.
P ulmonary arterial hypertension (PAH) is characterized by vascular remodeling and cellular proliferation that leads to narrowing and obstruction of small pulmonary arteries. The arteriopathy is clinically manifest as increased pulmonary vascular resistance and elevation of pulmonary arterial pressures. PAH is considered a progressive vasculopathy that ultimately leads to right heart failure an...
متن کاملProstacyclin therapy for pulmonary arterial hypertension: new directions.
Pulmonary arterial hypertension (PAH) is characterized by vasoconstriction and smooth muscle cell proliferation of the pulmonary arterioles, as well as in situ thrombosis of the small pulmonary arteries. Prostacyclin is involved in PAH vascular remodeling. It is unclear if decreased prostacyclin in the lungs is a cause or a consequence of PAH, but the relative lack of prostacyclin and its posit...
متن کاملProstacyclin therapies for the treatment of pulmonary arterial hypertension.
Prostacyclin and its analogues (prostanoids) are potent vasodilators and possess antithrombotic, antiproliferative and anti-inflammatory properties. Pulmonary hypertension (PH) is associated with vasoconstriction, thrombosis and proliferation, and the lack of endogenous prostacyclin may considerably contribute to this condition. This supports a strong rationale for prostanoid use as therapy for...
متن کاملAerosolised prostacyclin for pulmonary hypertension in neonates.
Aerosolised prostacyclin (PGI2) was administered to two neonates with pulmonary hypertension to dilate the pulmonary vessels selectively. The alveolar-arterial oxygen gradient fell from 73.2 (patient 1) and 71.8 kPa (patient 2) to 33.8 and 26.7 kPa respectively. Systemic blood pressure remained stable while pulmonary blood pressure declined in patient 1. When inhaled, PGI2 seems to improve oxyg...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Turkiye Klinikleri Archives of Lung
سال: 2017
ISSN: 1309-0119,2146-8958
DOI: 10.5336/archlung.2017-54938